Collaboration to develop a cancer therapy to be used with immune checkpoint inhibitors
Bristol-Myers Squibb and Nektar Therapeutics are working together to develop a cancer therapy [...]
Bristol-Myers Squibb and Nektar Therapeutics are working together to develop a cancer therapy [...]
The following is a Practice Update interview with Dr Hans Hammers, Associate [...]
In his keynote lecture at the American Society for Clinical [...]
This article, published in Nature just before Christmas, gives a [...]
There are now a number of licensed drug options available [...]
The European Association of Urology (EAU) guidelines are to be [...]
The Food and Drug Adminitration in the US has granted [...]
This article, published in UroToday this week, is a nice summary [...]
The following articles discuss the use of neoadjuvant therapy (drug [...]
Professor Thomas Powles, Barts Cancer Institute, London discusses the impact [...]